News
InterMune shares soar despite US FDA concerns
www.reuters.com
[Reuters] were up 56 percent at $ in afternoon Nasdaq trading. (Additional reporting Suzannah Benjamin in Bangalore; Editing by Lisa Von Ahn and John Wallace)
Anadys shares sink as investors spot flaws in Ph2
www.fiercebiotech.com
[FierceBiotech] '598's contribution to efficacy challenging which could complicate partnership discussions," Oppenheimer analyst Dr. Brian Abrahams noted to clients.
Brian Abrahams: Latest News, Videos and Photos of Brian Abrahams |...
timesofindia.indiatimes.com
Brian Abrahams News: Latest and Breaking News on Brian Abrahams. Explore Brian Abrahams profile at Times of India for photos, videos and latest news of Brian...
UPDATE 3-Protalix drug success puts new pressure on Genzyme - Reuters
www.reuters.com
* Company says drug could be approved in mid * Drug would compete with Genzyme's Cerezyme * Shares rise nearly 9 percent (Updates wi
sorted by relevance / date